pycnogenols: Clinical Trials

14 trials of pycnogenols, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 3 unknown, 2 not yet recruiting, 1 terminated. 9 Not applicable, 3 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable9Completed 4, Unknown 3, Not yet recruiting 2
Phase 23Completed 2, Terminated 1
Phase 32Completed 2

Follow pycnogenols: new trials by email Literature Review of pycnogenols trials Research Report on pycnogenols

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pycnogenol (French Maritime Pine Bark) for the Treatment of Gulf War Illness
Placebo, Pycnogenol, 100mg, Pycnogenol, 200mg - Gulf War Syndrome
Not applicableNot yet recruitingUniversity of Alabama at Birmingham202026-11-012026-09-21
The Improving Effects of French Maritime Pine Bark Extract on Antioxidation and Anti-inflammation a in Post-menopausal Women Based on Nutrigenomic Approach
French maritime pine bark extract, Placebo - Gene Expression, Nutrigenomics
Not applicableNot yet recruitingTaipei Medical University462026-09-072026-10-02
Pycnogenol® in Post-COVID-19 Condition
Pycnogenol®, Placebo - Post COVID-19 Condition, Long COVID
Phase 3CompletedUniversity of Zurich1532023-06-072026-04-29
Impact of Pycnogenol® on Gingival Inflammation
Pycnogenol, Placebo - Periodontitis
Not applicableCompletedWuerzburg University Hospital902022-03-172024-08-09
Improving Effects of Fish Oil Combined With Pine Bark Extract on Cognitive Decline
FOPE (fish oil + pine extract), FO (fish oil +placebo) - Mild Cognitive Impairment
Not applicableUnknownTaipei Medical University602021-11-112022-10-10
Mirtogenol and Bimatoprost on IOP in Hispanics With Open-Angle Glaucoma
Experimental: Oral Mirtogenol, Placebo of oral Dietary supplement - Glaucoma
Not applicableUnknownUniversity of Puerto Rico722020-05-152020-05-08
The Use of Pycnogenol® to Alleviate Menopausal Symptoms Induced or Increased by Breast and Gynecological Cancer Treatments
50 mg PYC and then placebo, 100 mg PYC and then placebo, Placebo and then 50 mg PYC - Climacteric; Menorrhagia, Menopausal, Menopause
Not applicableUnknownLegacy Health System402018-10-012018-10-12
Effect of Pycnogenol® on ADHD
Pycnogenol, Methylphenidate, Placebo - ADHD
Phase 3CompletedNina Hermans882017-09-012021-04-28
Effects of Botanical Microglia Modulators in Gulf War Illness
Boswellia Serrata, Curcumin, Epimedium - Gulf War Illness
Not applicableCompletedUniversity of Alabama at Birmingham362016-07-012025-01-24
Effects of Pycnogenol on Cardiac Fibrosis and Diastolic Dysfunction in Aged Hypertensive Subjects
Pycnogenol, Placebo - Cardiac Fibrosis, Diastolic Dysfunction
Phase 2TerminatedUniversity of Arizona92009-07-012013-12-17
Pycnogenol and Endothelial Function in Coronary Artery Disease
Pycnogenol, Placebo - Coronary Artery Disease
Not applicableCompletedUniversity of Zurich252008-03-012010-02-10
Understanding Pine Bark Extract as an Alternative Treatment (UPBEAT) Study
Pine Bark Extract (Flavangenol®) - Hypertension
Not applicableCompletedStanford University1302006-10-012014-04-02
Pycnogenol for the Treatment of Lymphedema of the Arm in Breast Cancer Survivors
Pycnogenol - Lymphedema, Breast
Phase 2CompletedNational Center for Complementary and Integrative Health (NCCIH)262003-08-012008-04-22
Pycnogenol for the Treatment of Lymphedema
Pycnogenol, Placebo - Lymphedema
Phase 2CompletedUniversity of Wisconsin, Madison22002-05-012015-10-05

Conditions studied

Hypertension (2)  ·  Lymphedema (2)  ·  Persian Gulf Syndrome (2)  ·  Attention Deficit Disorder with Hyperactivity (1)  ·  COVID-19 (1)  ·  Cognitive Dysfunction (1)  ·  Coronary Artery Disease (1)  ·  Glaucoma (1)  ·  Menorrhagia (1)  ·  Neoplasms (1)  ·  Periodontitis (1)  ·  Post-Acute COVID-19 Syndrome (1)

Sponsors

Taipei Medical University (2)  ·  University of Alabama at Birmingham (2)  ·  University of Zurich (2)  ·  Legacy Health System (1)  ·  National Center for Complementary and Integrative Health (NCCIH) (1)  ·  Nina Hermans (1)  ·  Stanford University (1)  ·  University of Arizona (1)  ·  University of Puerto Rico (1)  ·  University of Wisconsin, Madison (1)  ·  Wuerzburg University Hospital (1)

Countries

United States (7)  ·  Switzerland (2)  ·  Belgium (1)  ·  Germany (1)  ·  Puerto Rico (1)  ·  Taiwan (1)

Top investigators

Alexia Anagnostopoulos, MD (1)  ·  Georg Noll, MD (1)  ·  Jahn S Fehr, Prof., MD (1)  ·  James F. Cleary, M.B.B.S. (1)  ·  Jarred W Younger, PhD (1)  ·  Jarred Younger, PhD (1)  ·  Jorge R Miranda, Pham.D. (1)  ·  Nina Hermans, PhD (1)  ·  Paul R Hutson, PharmD (1)  ·  Randall S. Stafford MD, PhD (1)  ·  Reza Antoszewska, NP-C (1)  ·  Ronald R Watson, PhD (1)

Results publications

PMID 12751655, PMID 16488940, PMID 18618008, PMID 20876405, PMID 22240497, PMID 23316132, PMID 28351412, PMID 33802272, PMID 33802381, PMID 33915962, PMID 38879571, PMID 40362854, PMID 42118816, PMID 42790915